Neoplants
PrivateLast Round
Seed
Oct 27, 2022
Total Funding Raised
$20M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Neoplants is a biotechnology company that develops bioengineered plants and their microbiomes to purify indoor air by metabolizing volatile organic compounds (VOCs).
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, D2C Brands, Home & Lifestyle
Business Model
B2C
Customer Profile
Hardware Sales, Hardware + Subscription
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Neoplants Comparables
Compare Neoplants with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| AIRY Green Solutions | 77% | |
| Origen Air | 76% | |
| AlgenAir | 75% |
Neoplants Funding Rounds
Historical fundraising activity
Key People
Founding team and executive leadership
Neoplants Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Heartcore Capital | Seed |
| Collaborative Fund | Seed |
| Partech Partners | Seed |
| Entrepreneurs First | Seed |
| True Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 20, 2026
Open roles increased to 100, 7.3x the trailing average.
- Jul 13, 2026
Open roles increased to 25, 83% of headcount.
Neoplants Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Neoplants's valuation, stock price, and market status.
Is Neoplants a public or private company?
Neoplants is a private company.
What is the current stock price of Neoplants?
Neoplants is a private company, so its shares have no public market price. Caplight tracks Neoplants's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Neoplants worth (valuation)?
Valuation information for Neoplants is not publicly available.
Can I buy Neoplants stock?
Neoplants shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Neoplants's last funding round?
Neoplants's most recent funding round was Seed on October 27, 2022.
Who are the main investors in Neoplants?
Key investors in Neoplants include Heartcore Capital.
Will Neoplants IPO soon?
No public IPO plans have been announced for Neoplants.
How can I track Neoplants secondary market activity?
Caplight tracks bids, offers, and trades in Neoplants's shares on secondary markets.